The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk. Deming Yuetiva et al. Science translational medicine 2019 Aug (505)

Main|Search|PHGKB




Last Posted: Aug 16, 2019

---

• The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.
  Deming Yuetiva et al. Science translational medicine 2019 Aug (505)
• Can a Healthy Lifestyle Reduce Your Risk of Dementia Regardless of Your Genes?
  S Bowen et al, CDC Blog, August 14, 2019
• Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
  Yamazaki Yu et al. Nature reviews. Neurology 2019 Jul
• Sleep and Memory: The Promise of Precision Medicine.
  Carter Patricia et al. Sleep medicine clinics 2019 Sep 14(3) 371-378
• A Novel Ensemble-Based Machine Learning Algorithm to Predict the Conversion From Mild Cognitive Impairment to Alzheimer's Disease Using Socio-Demographic Characteristics, Clinical Information, and Neuropsychological Measures.
  Grassi Massimiliano et al. Frontiers in neurology 2019 10756
• Towards clinical utility of polygenic risk scores.
  Lambert Samuel A et al. Human molecular genetics 2019 Jul
• Should you find out if you’re at risk of Alzheimer’s?
  Genomes 2 People, Wall Street Journal, July 2019
• A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
  Zhang Chunyu et al. Journal of molecular neuroscience : MN 2019 Jul
• Application of artificial neural network model in diagnosis of Alzheimer's disease.
  Wang Naibo et al. BMC neurology 2019 Jul 19(1) 154
• Harnessing digital technology to predict, diagnose, monitor, and develop treatments for brain disorders.
  Stroud Clare et al. NPJ digital medicine 2019 244

more